{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T14:52:43Z","timestamp":1781794363271,"version":"3.54.5"},"reference-count":80,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T00:00:00Z","timestamp":1781740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T00:00:00Z","timestamp":1781740800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Biol Rep"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1007\/s11033-026-12137-7","type":"journal-article","created":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T12:25:52Z","timestamp":1781785552000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Mechanistic interactions between curcumin and statins: pharmacological convergence and therapeutic implications"],"prefix":"10.1007","volume":"53","author":[{"given":"Zahra Najafi","family":"Arab","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seyed Mehrad","family":"Razavi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kimia","family":"Golikhatir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arezoo","family":"Momeni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nazanin","family":"Hashemi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fatemeh","family":"Ramezani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saeideh","family":"Momtaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali H.","family":"Eid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tannaz","family":"Jamialahmadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Prashant","family":"Kesharwani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amir Hossein","family":"Abdolghaffari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amirhossein","family":"Sahebkar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,18]]},"reference":[{"issue":"52","key":"12137_CR1","doi-asserted-by":"publisher","first-page":"37161","DOI":"10.1074\/jbc.274.52.37161","volume":"274","author":"B Hsiang","year":"1999","unstructured":"Hsiang B, Zhu Y, Wang Z, Wu Y, Sasseville V, Yang W-P et al (1999) A novel human hepatic organic anion transporting polypeptide (OATP2): identification of a liver-specific human organic anion transporting polypeptide and identification of rat and human hydroxymethylglutaryl-CoA reductase inhibitor transporters. J Biol Chem 274(52):37161\u201337168","journal-title":"J Biol Chem"},{"key":"12137_CR2","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1016\/j.phrs.2018.08.014","volume":"135","author":"A Bahrami","year":"2018","unstructured":"Bahrami A, Parsamanesh N, Atkin SL, Banach M, Sahebkar A (2018) Effect of statins on toll-like receptors: a new insight to pleiotropic effects. Pharmacol Res 135:230\u2013238","journal-title":"Pharmacol Res"},{"key":"12137_CR3","doi-asserted-by":"crossref","unstructured":"Kandelouei T, Abbasifard M, Imani D, Aslani S, Razi B, Fasihi M et al (2022) Effect of Statins on Serum level of hs-CRP and CRP in patients with cardiovascular diseases: A systematic review and meta-analysis of randomized controlled trials. Mediators of Inflammation. ;2022","DOI":"10.1155\/2022\/8732360"},{"issue":"6","key":"12137_CR4","doi-asserted-by":"publisher","first-page":"1432","DOI":"10.5114\/aoms.2020.100304","volume":"16","author":"N Shakour","year":"2020","unstructured":"Shakour N, Ruscica M, Hadizadeh F, Cirtori C, Banach M, Jamialahmadi T et al (2020) Statins and C-reactive protein: In silico evidence on direct interaction. Archives Med Sci 16(6):1432\u20131439","journal-title":"Archives Med Sci"},{"issue":"1","key":"12137_CR5","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1742-2094-9-81","volume":"9","author":"E Esposito","year":"2012","unstructured":"Esposito E, Rinaldi B, Mazzon E, Donniacuo M, Impellizzeri D, Paterniti I et al (2012) Anti-inflammatory effect of simvastatin in an experimental model of spinal cord trauma: involvement of PPAR-\u03b1. J Neuroinflamm 9(1):1\u201317","journal-title":"J Neuroinflamm"},{"issue":"9","key":"12137_CR6","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1016\/j.numecd.2013.05.002","volume":"23","author":"\u017d Reiner","year":"2013","unstructured":"Reiner \u017d (2013) Managing the residual cardiovascular disease risk associated with HDL-cholesterol and triglycerides in statin-treated patients: a clinical update. Nutr Metabolism Cardiovasc Dis 23(9):799\u2013807","journal-title":"Nutr Metabolism Cardiovasc Dis"},{"key":"12137_CR7","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1016\/j.lfs.2018.09.025","volume":"211","author":"A Iqubal","year":"2018","unstructured":"Iqubal A, Sharma S, Sharma K, Bhavsar A, Hussain I, Iqubal MK et al (2018) Intranasally administered pitavastatin ameliorates pentylenetetrazol-induced neuroinflammation, oxidative stress and cognitive dysfunction. Life Sci 211:172\u2013181","journal-title":"Life Sci"},{"issue":"1\u20132","key":"12137_CR8","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/S0022-510X(01)00529-9","volume":"187","author":"B Cucchiara","year":"2001","unstructured":"Cucchiara B, Kasner SE (2001) Use of statins in CNS disorders. J Neurol Sci 187(1\u20132):81\u201389","journal-title":"J Neurol Sci"},{"issue":"5","key":"12137_CR9","doi-asserted-by":"publisher","first-page":"1615","DOI":"10.3892\/etm.2015.2749","volume":"10","author":"D Perrone","year":"2015","unstructured":"Perrone D, Ardito F, Giannatempo G, Dioguardi M, Troiano G, Lo Russo L et al (2015) Biological and therapeutic activities, and anticancer properties of curcumin. Exp Ther Med 10(5):1615\u20131623","journal-title":"Exp Ther Med"},{"issue":"5","key":"12137_CR10","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1007\/s10571-019-00671-x","volume":"39","author":"J Yuan","year":"2019","unstructured":"Yuan J, Botchway BO, Zhang Y, Tan X, Wang X, Liu X (2019) Curcumin can improve spinal cord injury by inhibiting TGF-\u03b2-SOX9 signaling pathway. Cell Mol Neurobiol 39(5):569\u2013575","journal-title":"Cell Mol Neurobiol"},{"issue":"4","key":"12137_CR11","doi-asserted-by":"publisher","first-page":"1462","DOI":"10.1002\/ptr.7737","volume":"37","author":"H Heidari","year":"2023","unstructured":"Heidari H, Bagherniya M, Majeed M, Sathyapalan T, Jamialahmadi T, Sahebkar A (2023) Curcumin-piperine co-supplementation and human health: A comprehensive review of preclinical and clinical studies. Phytother Res 37(4):1462\u20131487","journal-title":"Phytother Res"},{"issue":"5","key":"12137_CR12","doi-asserted-by":"publisher","first-page":"760","DOI":"10.3390\/life12050760","volume":"12","author":"D Khayatan","year":"2022","unstructured":"Khayatan D, Razavi SM, Arab ZN, Khanahmadi M, Momtaz S, Butler AE et al (2022) Regulatory Effects of Statins on SIRT1 and Other Sirtuins in Cardiovascular Diseases. Life 12(5):760","journal-title":"Life"},{"issue":"3","key":"12137_CR13","doi-asserted-by":"publisher","first-page":"1069","DOI":"10.1007\/s10787-023-01136-w","volume":"31","author":"M Sadeghi","year":"2023","unstructured":"Sadeghi M, Dehnavi S, Asadirad A, Xu S, Majeed M, Jamialahmadi T et al (2023) Curcumin and chemokines: mechanism of action and therapeutic potential in inflammatory diseases. Inflammopharmacology 31(3):1069\u20131093","journal-title":"Inflammopharmacology"},{"issue":"5","key":"12137_CR14","doi-asserted-by":"publisher","first-page":"2201","DOI":"10.1007\/s10787-023-01265-2","volume":"31","author":"HS Shamsnia","year":"2023","unstructured":"Shamsnia HS, Roustaei M, Ahmadvand D, Butler AE, Amirlou D, Soltani S et al (2023) Impact of curcumin on p38 MAPK: therapeutic implications. Inflammopharmacology 31(5):2201\u20132212","journal-title":"Inflammopharmacology"},{"key":"12137_CR15","doi-asserted-by":"crossref","unstructured":"Bahari H, Omidian K, Asadi Z, Golafrouz H, Rafiei H (2025) Efficacy of curcumin\/turmeric on inflammation and oxidative stress in prediabetes and type 2 diabetes: a systematic review and dose-response meta-analysis. 1568\u20135608","DOI":"10.1007\/s10787-025-02038-9"},{"key":"12137_CR16","doi-asserted-by":"crossref","unstructured":"Saberi-Karimian M, Keshvari M, Ghayour-Mobarhan M, Salehizadeh L, Rahmani S, Behnam B et al (2020) Effects of curcuminoids on inflammatory status in patients with non-alcoholic fatty liver disease: A randomized controlled trial. Complement Ther Med 49","DOI":"10.1016\/j.ctim.2020.102322"},{"issue":"7","key":"12137_CR17","doi-asserted-by":"publisher","first-page":"855","DOI":"10.3390\/nu10070855","volume":"10","author":"MH Farzaei","year":"2018","unstructured":"Farzaei MH, Zobeiri M, Parvizi F, El-Senduny FF, Marmouzi I, Coy-Barrera E et al (2018) Curcumin in liver diseases: a systematic review of the cellular mechanisms of oxidative stress and clinical perspective. Nutrients 10(7):855","journal-title":"Nutrients"},{"issue":"6","key":"12137_CR18","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1021\/mp700113r","volume":"4","author":"P Anand","year":"2007","unstructured":"Anand P, Kunnumakkara AB, Newman RA, Aggarwal BB (2007) Bioavailability of curcumin: problems and promises. Mol Pharm 4(6):807\u2013818","journal-title":"Mol Pharm"},{"issue":"3","key":"12137_CR19","doi-asserted-by":"publisher","first-page":"264","DOI":"10.3390\/molecules21030264","volume":"21","author":"M Pulido-Moran","year":"2016","unstructured":"Pulido-Moran M, Moreno-Fernandez J, Ramirez-Tortosa C, Ramirez-Tortosa M (2016) Curcumin Health Molecules 21(3):264","journal-title":"Curcumin Health Molecules"},{"key":"12137_CR20","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/B978-0-12-800173-8.00003-9","volume":"39","author":"ML Lestari","year":"2014","unstructured":"Lestari ML, Indrayanto G, Curcumin (2014) Profiles Drug Subst Excip Relat Methodol 39:113\u2013204","journal-title":"Profiles Drug Subst Excip Relat Methodol"},{"issue":"2","key":"12137_CR21","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1002\/ptr.6226","volume":"33","author":"R Tabrizi","year":"2019","unstructured":"Tabrizi R, Vakili S, Akbari M, Mirhosseini N, Lankarani KB, Rahimi M et al (2019) The effects of curcumin-containing supplements on biomarkers of inflammation and oxidative stress: A systematic review and meta-analysis of randomized controlled trials. Phytother Res 33(2):253\u2013262","journal-title":"Phytother Res"},{"issue":"6","key":"12137_CR22","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1002\/ptr.6037","volume":"32","author":"M Mantzorou","year":"2018","unstructured":"Mantzorou M, Pavlidou E, Vasios G, Tsagalioti E, Giaginis C (2018) Effects of curcumin consumption on human chronic diseases: A narrative review of the most recent clinical data. Phytother Res 32(6):957\u2013975","journal-title":"Phytother Res"},{"key":"12137_CR23","doi-asserted-by":"crossref","unstructured":"Sun D, Wang J, Li X, Peng J, Wang S (2026) Advances and perspectives in curcumin regulation of systemic metabolism: A focus on multi-organ mechanisms. LID\u2009\u2013\u200910.3390\/antiox15010109 [doi] LID\u2009\u2013\u2009109. 2076\u20133921","DOI":"10.3390\/antiox15010109"},{"key":"12137_CR24","doi-asserted-by":"crossref","unstructured":"Dastani M, Rahimi HR, Askari VR, Jaafari MR, Jarahi L, Yadollahi A et al (2023) Three months of combination therapy with nano-curcumin reduces the inflammation and lipoprotein (a) in type 2 diabetic patients with mild to moderate coronary artery disease: Evidence of a randomized, double-blinded, placebo-controlled clinical trial. 1872\u20138081","DOI":"10.1002\/biof.1874"},{"key":"12137_CR25","doi-asserted-by":"crossref","unstructured":"Lan Z, Tan F, He J, Liu J, Lu M, Hu Z et al (2024) Curcumin-primed olfactory mucosa-derived mesenchymal stem cells mitigate cerebral ischemia\/reperfusion injury-induced neuronal PANoptosis by modulating microglial polarization. 1618-095X","DOI":"10.1016\/j.phymed.2024.155635"},{"key":"12137_CR26","doi-asserted-by":"crossref","unstructured":"Goyal S, Beniwal SK, Agarwal P, Brar RK, Jain P, Kumar HS et al (2025) Efficacy and Safety of Curcumin as an Adjuvant to Standard Chemotherapy in Advanced and Metastatic Breast Cancer Patients: A Randomized Controlled Study. 1099\u20131573","DOI":"10.1002\/ptr.70086"},{"issue":"4","key":"12137_CR27","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1016\/S0090-9556(24)15211-7","volume":"27","author":"MH Pan","year":"1999","unstructured":"Pan MH, Huang TM, Lin JK (1999) Biotransformation of curcumin through reduction and glucuronidation in mice. Drug Metab Dispos 27(4):486\u2013494","journal-title":"Drug Metab Dispos"},{"issue":"1","key":"12137_CR28","first-page":"105","volume":"11","author":"CR Ireson","year":"2002","unstructured":"Ireson CR, Jones DJ, Orr S, Coughtrie MW, Boocock DJ, Williams ML et al (2002) Metabolism of the cancer chemopreventive agent curcumin in human and rat intestine. Cancer Epidemiol Biomarkers Prev 11(1):105\u2013111","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"5","key":"12137_CR29","doi-asserted-by":"publisher","first-page":"243","DOI":"10.5551\/jat.9.243","volume":"9","author":"M Naito","year":"2002","unstructured":"Naito M, Wu X, Nomura H, Kodama M, Kato Y, Kato Y et al (2002) The protective effects of tetrahydrocurcumin on oxidative stress in cholesterol-fed rabbits. J Atheroscler Thromb 9(5):243\u2013250","journal-title":"J Atheroscler Thromb"},{"issue":"3","key":"12137_CR30","first-page":"1058","volume":"61","author":"C Ireson","year":"2001","unstructured":"Ireson C, Orr S, Jones DJ, Verschoyle R, Lim CK, Luo JL et al (2001) Characterization of metabolites of the chemopreventive agent curcumin in human and rat hepatocytes and in the rat in vivo, and evaluation of their ability to inhibit phorbol ester-induced prostaglandin E2 production. Cancer Res 61(3):1058\u20131064","journal-title":"Cancer Res"},{"issue":"6","key":"12137_CR31","doi-asserted-by":"publisher","first-page":"2557","DOI":"10.2353\/ajpath.2009.090417","volume":"175","author":"T Hamaguchi","year":"2009","unstructured":"Hamaguchi T, Ono K, Murase A, Yamada M (2009) Phenolic compounds prevent Alzheimer\u2019s pathology through different effects on the amyloid-beta aggregation pathway. Am J Pathol 175(6):2557\u20132565","journal-title":"Am J Pathol"},{"key":"12137_CR32","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.molimm.2019.09.020","volume":"116","author":"J Zhang","year":"2019","unstructured":"Zhang J, Zheng Y, Luo Y, Du Y, Zhang X, Fu J (2019) Curcumin inhibits LPS-induced neuroinflammation by promoting microglial M2 polarization via TREM2\/ TLR4\/ NF-\u03baB pathways in BV2 cells. Mol Immunol 116:29\u201337","journal-title":"Mol Immunol"},{"issue":"8","key":"12137_CR33","doi-asserted-by":"publisher","first-page":"1745","DOI":"10.1002\/ptr.6642","volume":"34","author":"M Ashrafizadeh","year":"2020","unstructured":"Ashrafizadeh M, Rafiei H, Mohammadinejad R, Afshar EG, Farkhondeh T, Samarghandian S (2020) Potential therapeutic effects of curcumin mediated by JAK\/STAT signaling pathway: A review. Phytother Res 34(8):1745\u20131760","journal-title":"Phytother Res"},{"key":"12137_CR34","doi-asserted-by":"publisher","first-page":"153238","DOI":"10.1016\/j.phymed.2020.153238","volume":"75","author":"M Olcum","year":"2020","unstructured":"Olcum M, Tastan B, Ercan I, Eltutan IB, Genc S (2020) Inhibitory effects of phytochemicals on NLRP3 inflammasome activation: A review. Phytomedicine 75:153238","journal-title":"Phytomedicine"},{"key":"12137_CR35","doi-asserted-by":"crossref","unstructured":"Shah A, Amini-Nik S (2017) The role of phytochemicals in the inflammatory phase of wound healing. Int J Mol Sci 18(5)","DOI":"10.3390\/ijms18051068"},{"key":"12137_CR36","doi-asserted-by":"crossref","unstructured":"Jakubczyk K, Dru\u017cga A, Katarzyna J, Skonieczna-\u017bydecka K (2020) Antioxidant potential of curcumin-A meta-analysis of randomized clinical trials. Antioxid (Basel) 9(11)","DOI":"10.3390\/antiox9111092"},{"key":"12137_CR37","doi-asserted-by":"publisher","first-page":"156144","DOI":"10.1016\/j.cyto.2023.156144","volume":"164","author":"MJ Dehzad","year":"2023","unstructured":"Dehzad MJ, Ghalandari H, Nouri M, Askarpour M (2023) Antioxidant and anti-inflammatory effects of curcumin\/turmeric supplementation in adults: A GRADE-assessed systematic review and dose-response meta-analysis of randomized controlled trials. Cytokine 164:156144","journal-title":"Cytokine"},{"key":"12137_CR38","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.neuroscience.2019.02.020","volume":"406","author":"S Abrahams","year":"2019","unstructured":"Abrahams S, Haylett WL, Johnson G, Carr JA, Bardien S (2019) Antioxidant effects of curcumin in models of neurodegeneration, aging, oxidative and nitrosative stress: A review. Neuroscience 406:1\u201321","journal-title":"Neuroscience"},{"key":"12137_CR39","doi-asserted-by":"publisher","first-page":"111119","DOI":"10.1016\/j.biopha.2020.111119","volume":"134","author":"A Zia","year":"2021","unstructured":"Zia A, Farkhondeh T, Pourbagher-Shahri AM, Samarghandian S (2021) The role of curcumin in aging and senescence: Molecular mechanisms. Biomed Pharmacother 134:111119","journal-title":"Biomed Pharmacother"},{"key":"12137_CR40","doi-asserted-by":"crossref","unstructured":"Akter K, Gul K, Mumtaz S (2025) Revisiting curcumin in cancer therapy: Recent insights into molecular mechanisms, nanoformulations, and synergistic combinations. LID\u2009\u2013\u200910.3390\/cimb47090716 [doi] LID\u2009\u2013\u2009716. 1467\u20133045","DOI":"10.3390\/cimb47090716"},{"issue":"10","key":"12137_CR41","doi-asserted-by":"publisher","first-page":"6530","DOI":"10.1002\/jcp.26620","volume":"233","author":"L Hamzehzadeh","year":"2018","unstructured":"Hamzehzadeh L, Atkin SL, Majeed M, Butler AE, Sahebkar A (2018) The versatile role of curcumin in cancer prevention and treatment: A focus on PI3K\/AKT pathway. J Cell Physiol 233(10):6530\u20136537","journal-title":"J Cell Physiol"},{"key":"12137_CR42","doi-asserted-by":"crossref","unstructured":"Shafabakhsh R, Pourhanifeh MH, Mirzaei HR, Sahebkar A, Asemi Z, Mirzaei H (2019) Targeting regulatory T cells by curcumin: A potential for cancer immunotherapy. Pharmacol Res 147","DOI":"10.1016\/j.phrs.2019.104353"},{"issue":"2","key":"12137_CR43","first-page":"645","volume":"35","author":"NG Vallianou","year":"2015","unstructured":"Vallianou NG, Evangelopoulos A, Schizas N, Kazazis C (2015) Potential anticancer properties and mechanisms of action of curcumin. Anticancer Res 35(2):645\u2013651","journal-title":"Anticancer Res"},{"issue":"3","key":"12137_CR44","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1097\/MOL.0b013e3283462288","volume":"22","author":"JM Lou-Bonafonte","year":"2011","unstructured":"Lou-Bonafonte JM, Arnal C, Osada J (2011) New genes involved in hepatic steatosis. Curr Opin Lipidol 22(3):159\u2013164","journal-title":"Curr Opin Lipidol"},{"issue":"12","key":"12137_CR45","doi-asserted-by":"publisher","first-page":"3439","DOI":"10.1007\/s10620-011-1767-y","volume":"56","author":"W Nseir","year":"2011","unstructured":"Nseir W, Shalata A, Marmor A, Assy N (2011) Mechanisms linking nonalcoholic fatty liver disease with coronary artery disease. Dig Dis Sci 56(12):3439\u20133449","journal-title":"Dig Dis Sci"},{"issue":"12","key":"12137_CR46","doi-asserted-by":"publisher","first-page":"1829","DOI":"10.1002\/mnfr.201100440","volume":"55","author":"SK Shin","year":"2011","unstructured":"Shin SK, Ha TY, McGregor RA, Choi MS (2011) Long-term curcumin administration protects against atherosclerosis via hepatic regulation of lipoprotein cholesterol metabolism. Mol Nutr Food Res 55(12):1829\u20131840","journal-title":"Mol Nutr Food Res"},{"issue":"11","key":"12137_CR47","doi-asserted-by":"publisher","first-page":"1374","DOI":"10.1055\/s-2008-1081316","volume":"74","author":"X Dou","year":"2008","unstructured":"Dou X, Fan C, Wo L, Yan J, Qian Y, Wo X (2008) Curcumin up-regulates LDL receptor expression via the sterol regulatory element pathway in HepG2 cells. Planta Med 74(11):1374\u20131379","journal-title":"Planta Med"},{"key":"12137_CR48","doi-asserted-by":"crossref","unstructured":"Stohs SJ, Chen O, Ray SD, Ji J, Bucci LR, Preuss HG (2020) Highly bioavailable forms of curcumin and promising avenues for curcumin-based research and application: A Review. Molecules 25(6)","DOI":"10.3390\/molecules25061397"},{"issue":"4","key":"12137_CR49","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1007\/s13318-019-00545-z","volume":"44","author":"VS Ipar","year":"2019","unstructured":"Ipar VS, Dsouza A, Devarajan PV (2019) Enhancing curcumin oral bioavailability through nanoformulations. Eur J Drug Metab Pharmacokinet 44(4):459\u2013480","journal-title":"Eur J Drug Metab Pharmacokinet"},{"issue":"1","key":"12137_CR50","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1049\/iet-nbt.2016.0062","volume":"11","author":"JBV Ramakrishna","year":"2017","unstructured":"Ramakrishna JBV, Madhusudhan S (2017) Preparation and characterisation of atorvastatin and curcumin-loaded chitosan nanoformulations for oral delivery in atherosclerosis. IET Nanobiotechnol 11(1):96\u2013103","journal-title":"IET Nanobiotechnol"},{"key":"12137_CR51","unstructured":"Bansal AB, Cassagnol M (2022) HMG-CoA reductase inhibitors. StatPearls. Treasure Island (FL): StatPearls Publishing Copyright \u00a9 2022. StatPearls Publishing LLC."},{"key":"12137_CR52","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/bs.acc.2015.10.005","volume":"73","author":"EE Egom","year":"2016","unstructured":"Egom EE, Hafeez H (2016) Biochemistry of Statins. Adv Clin Chem 73:127\u2013168","journal-title":"Adv Clin Chem"},{"issue":"11","key":"12137_CR53","doi-asserted-by":"publisher","first-page":"20607","DOI":"10.3390\/ijms151120607","volume":"15","author":"AJ McFarland","year":"2014","unstructured":"McFarland AJ, Anoopkumar-Dukie S, Arora DS, Grant GD, McDermott CM, Perkins AV et al (2014) Molecular mechanisms underlying the effects of statins in the central nervous system. Int J Mol Sci 15(11):20607\u201320637","journal-title":"Int J Mol Sci"},{"key":"12137_CR54","doi-asserted-by":"publisher","first-page":"22","DOI":"10.3390\/ijms21228745","volume":"21","author":"C Murphy","year":"2020","unstructured":"Murphy C, Deplazes E, Cranfield CG, Garcia A (2020) The role of structure and biophysical properties in the pleiotropic effects of statins. Int J Mol Sci 21:22","journal-title":"Int J Mol Sci"},{"key":"12137_CR55","doi-asserted-by":"crossref","unstructured":"Preta G (2022) Role of Lactone and Acid Forms in the Pleiotropic Effects of Statins. Pharmaceutics. ;14(9)","DOI":"10.3390\/pharmaceutics14091899"},{"issue":"6","key":"12137_CR56","first-page":"631","volume":"32","author":"S Ramkumar","year":"2016","unstructured":"Ramkumar S, Raghunath A, Raghunath S (2016) Statin Therapy: Review of Safety and Potential Side Effects. Acta Cardiol Sin 32(6):631\u2013639","journal-title":"Acta Cardiol Sin"},{"issue":"2","key":"12137_CR57","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1007\/s40256-016-0197-9","volume":"17","author":"J Mill\u00e1n N\u00fa\u00f1ez-Cort\u00e9s","year":"2017","unstructured":"Mill\u00e1n N\u00fa\u00f1ez-Cort\u00e9s J, Cases Amen\u00f3s A, Ascaso Gimilio JF, Barrios Alonso V, Pascual Fuster V, Pedro-Botet Montoya JC et al (2017) Consensus on the statin of choice in patients with impaired glucose metabolism: Results of the DIANA study. Am J Cardiovasc Drugs 17(2):135\u2013142","journal-title":"Am J Cardiovasc Drugs"},{"issue":"2","key":"12137_CR58","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1007\/s12016-020-08791-9","volume":"60","author":"K Koushki","year":"2021","unstructured":"Koushki K, Shahbaz SK, Mashayekhi K, Sadeghi M, Zayeri ZD, Taba MY et al (2021) Anti-inflammatory action of statins in cardiovascular disease: the Role of inflammasome and toll-like receptor pathways. Clin Rev Allergy Immunol 60(2):175\u2013199","journal-title":"Clin Rev Allergy Immunol"},{"key":"12137_CR59","doi-asserted-by":"publisher","first-page":"13","DOI":"10.4137\/LPI.S37450","volume":"9","author":"JT Davies","year":"2016","unstructured":"Davies JT, Delfino SF, Feinberg CE, Johnson MF, Nappi VL, Olinger JT et al (2016) Current and emerging uses of statins in clinical therapeutics: A Review. Lipid Insights 9:13\u201329","journal-title":"Lipid Insights"},{"issue":"1","key":"12137_CR60","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1111\/imm.12902","volume":"154","author":"R Zeiser","year":"2018","unstructured":"Zeiser R (2018) Immune modulatory effects of statins. Immunology 154(1):69\u201375","journal-title":"Immunology"},{"key":"12137_CR61","doi-asserted-by":"crossref","unstructured":"Motoji Y, Fukazawa R, Matsui R, Nagi-Miura N, Miyagi Y, Itoh Y et al (2022) Kawasaki disease-like vasculitis facilitates atherosclerosis, and statin shows a significant antiatherosclerosis and anti-inflammatory effect in a kawasaki disease model mouse. Biomedicines. ;10(8)","DOI":"10.3390\/biomedicines10081794"},{"key":"12137_CR62","doi-asserted-by":"crossref","unstructured":"Mansouri A, Reiner \u017d, Ruscica M, Tedeschi-Reiner E, Radbakhsh S, Bagheri Ekta M et al (2022) Antioxidant effects of statins by modulating Nrf2 and Nrf2\/HO-1 signaling in different diseases. J Clin Med. ;11(5)","DOI":"10.3390\/jcm11051313"},{"key":"12137_CR63","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.plipres.2015.08.003","volume":"60","author":"G Ferretti","year":"2015","unstructured":"Ferretti G, Bacchetti T, Sahebkar A (2015) Effect of statin therapy on paraoxonase-1 status: A systematic review and meta-analysis of 25 clinical trials. Prog Lipid Res 60:50\u201373","journal-title":"Prog Lipid Res"},{"issue":"4","key":"12137_CR64","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1007\/s11745-010-3517-x","volume":"46","author":"SMR Parizadeh","year":"2011","unstructured":"Parizadeh SMR, Azarpazhooh MR, Moohebati M, Nematy M, Ghayour-Mobarhan M, Tavallaie S et al (2011) Simvastatin therapy reduces prooxidant-antioxidant balance: Results of a placebo-controlled cross-over trial. Lipids 46(4):333\u2013340","journal-title":"Lipids"},{"issue":"7","key":"12137_CR65","first-page":"e27032","volume":"14","author":"S Khazaaleh","year":"2022","unstructured":"Khazaaleh S, Sarmini MT, Alomari M, Al Momani L, El Kurdi B, Asfari M et al (2022) Statin use reduces the risk of hepatocellular carcinoma: An updated meta-analysis and systematic review. Cureus 14(7):e27032","journal-title":"Cureus"},{"issue":"2","key":"12137_CR66","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1016\/j.bcp.2003.09.006","volume":"67","author":"N Ruiz-Velasco","year":"2004","unstructured":"Ruiz-Velasco N, Dom\u00ednguez A, Vega MA (2004) Statins upregulate CD36 expression in human monocytes, an effect strengthened when combined with PPAR-gamma ligands Putative contribution of Rho GTPases in statin-induced CD36 expression. Biochem Pharmacol 67(2):303\u2013313","journal-title":"Biochem Pharmacol"},{"key":"12137_CR67","doi-asserted-by":"crossref","unstructured":"Abu-Dief AM, Shaaban EA, Abdelhaleem NG, Mohamed DS (2022) The possible role of nanocurcumin in rat model of statin induced myopathy: Histological and immune histochemical study. J Adv Med Med Res. :76\u201388","DOI":"10.9734\/jammr\/2022\/v34i231263"},{"issue":"3","key":"12137_CR68","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1080\/00498254.2016.1183060","volume":"47","author":"X Zhou","year":"2017","unstructured":"Zhou X, Zhang F, Chen C, Guo Z, Liu J, Yu J et al (2017) Impact of curcumin on the pharmacokinetics of rosuvastatin in rats and dogs based on the conjugated metabolites. Xenobiotica 47(3):267\u2013275","journal-title":"Xenobiotica"},{"key":"12137_CR69","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1016\/j.phrs.2018.01.023","volume":"132","author":"LS Einbond","year":"2018","unstructured":"Einbond LS, Manservisi F, Wu HA, Balick M, Antonetti V, Vornoli A et al (2018) A transcriptomic analysis of turmeric: Curcumin represses the expression of cholesterol biosynthetic genes and synergizes with simvastatin. Pharmacol Res 132:176\u2013187","journal-title":"Pharmacol Res"},{"issue":"2","key":"12137_CR70","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1002\/jbm.a.37292","volume":"110","author":"P Heydari","year":"2022","unstructured":"Heydari P, Zargar Kharazi A, Asgary S, Parham S (2022) Comparing the wound healing effect of a controlled release wound dressing containing curcumin\/ciprofloxacin and simvastatin\/ciprofloxacin in a rat model: A preclinical study. J Biomed Mater Res A 110(2):341\u2013352","journal-title":"J Biomed Mater Res A"},{"issue":"3","key":"12137_CR71","doi-asserted-by":"publisher","first-page":"1507","DOI":"10.21608\/ijma.2021.61857.1267","volume":"3","author":"AA Eissa","year":"2021","unstructured":"Eissa AA, Abdelateef AS, Elkotby HM (2021) Potential effect of curcumin versus atorvastatin on hepatic and metabolic changes in rat model of metabolic syndrome. Int J Med Arts 3(3):1507\u20131515","journal-title":"Int J Med Arts"},{"key":"12137_CR72","doi-asserted-by":"publisher","first-page":"649","DOI":"10.2147\/IJN.S189819","volume":"14","author":"X Li","year":"2019","unstructured":"Li X, Xiao H, Lin C, Sun W, Wu T, Wang J et al (2019) Synergistic effects of liposomes encapsulating atorvastatin calcium and curcumin and targeting dysfunctional endothelial cells in reducing atherosclerosis. Int J Nanomed 14:649\u2013665","journal-title":"Int J Nanomed"},{"issue":"6","key":"12137_CR73","doi-asserted-by":"publisher","first-page":"1377","DOI":"10.17305\/bb.2024.11091","volume":"25","author":"D Lagumd\u017eija","year":"2025","unstructured":"Lagumd\u017eija D, Hamzi\u0107 Mehmedba\u0161i\u0107 A, Jesenkovi\u0107 DA, Kudi\u0107 B, Kapi\u0107 D, \u0106osovi\u0107 E et al (2025) Curcumin and its combination with a reduced dose of rosuvastatin: A promising therapy for chronic kidney disease and associated dyslipidemia in rat animal models. Biomol Biomed 25(6):1377\u20131388","journal-title":"Biomol Biomed"},{"issue":"3","key":"12137_CR74","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1080\/07315724.2010.10719835","volume":"29","author":"DG Popovich","year":"2010","unstructured":"Popovich DG, Tiaras F, Yeo CR, Zhang W (2010) Lovastatin interacts with natural products to influence cultured hepatocarcinoma cell (hep-g2) growth. J Am Coll Nutr 29(3):204\u2013210","journal-title":"J Am Coll Nutr"},{"key":"12137_CR75","doi-asserted-by":"crossref","unstructured":"Pehlivanovi\u0107 B, \u010caklovica K, \u0160ap\u010danin A, Lagumd\u017eija D, Omerovi\u0107 N, \u017diga Smaji\u0107 N et al (eds) (2021) Potentially new synergistic combination of curcumin and rosuvastatin: An in vitro study. International Conference on Medical and Biological Engineering; Springer","DOI":"10.1007\/978-3-030-73909-6_49"},{"issue":"11","key":"12137_CR76","doi-asserted-by":"publisher","first-page":"2133","DOI":"10.1002\/mnfr.201400366","volume":"58","author":"MH Tai","year":"2014","unstructured":"Tai MH, Chen PK, Chen PY, Wu MJ, Ho CT, Yen JH (2014) Curcumin enhances cell-surface LDLR level and promotes LDL uptake through downregulation of PCSK9 gene expression in HepG2 cells. Mol Nutr Food Res 58(11):2133\u20132145","journal-title":"Mol Nutr Food Res"},{"issue":"2","key":"12137_CR77","doi-asserted-by":"publisher","first-page":"126","DOI":"10.3748\/wjg.v18.i2.126","volume":"18","author":"F Ye","year":"2012","unstructured":"Ye F, Zhang GH, Guan BX, Xu XC (2012) Suppression of esophageal cancer cell growth using curcumin, (-)-epigallocatechin-3-gallate and lovastatin. World J Gastroenterol 18(2):126\u2013135","journal-title":"World J Gastroenterol"},{"key":"12137_CR78","doi-asserted-by":"publisher","first-page":"109570","DOI":"10.1016\/j.bioorg.2026.109570","volume":"172","author":"V Rawat","year":"2026","unstructured":"Rawat V, Rao SP, Sarwa KK, Dewangan S, Sharma T (2026) Synthesis, characterization, and nanoparticle formulation and evaluation of rosuvastatin-curcumin conjugate for atherosclerosis management. Bioorg Chem 172:109570","journal-title":"Bioorg Chem"},{"key":"12137_CR79","unstructured":"Manogaran E, Ramanathan M, RamaRao T (2015) Neuroprotective effect of curcumin against cholesterol induced neuroinflammation in in-vitro and in-vivo models. Journal of Pharmaceutical Sciences and Research 7(4):189"},{"key":"12137_CR80","doi-asserted-by":"publisher","first-page":"944","DOI":"10.1016\/j.biopha.2017.07.151","volume":"94","author":"R Meena","year":"2017","unstructured":"Meena R, Kumar S, kumar R, Gaharwar US, Rajamani P (2017) PLGA-CTAB curcumin nanoparticles: Fabrication, characterization and molecular basis of anticancer activity in triple negative breast cancer cell lines (MDA-MB-231 cells). Biomed Pharmacotherapy 94:944\u2013954","journal-title":"Biomed Pharmacotherapy"}],"container-title":["Molecular Biology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-026-12137-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11033-026-12137-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-026-12137-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T14:03:16Z","timestamp":1781791396000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11033-026-12137-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,18]]},"references-count":80,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,12]]}},"alternative-id":["12137"],"URL":"https:\/\/doi.org\/10.1007\/s11033-026-12137-7","relation":{},"ISSN":["0301-4851","1573-4978"],"issn-type":[{"value":"0301-4851","type":"print"},{"value":"1573-4978","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,18]]},"assertion":[{"value":"9 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"948"}}